RICOVER-@ patients with VDD ( @ ng/mL ) and vitamin D levels more than @ ng/mL treated with rituximab had @-year event-free survival ( EFS ) of @ % and @ % and @-year overall survival ( OS ) of @ % and @ % , respectively .